Seizure suppression in kindled rats by intraventricular grafting of an adenosine releasing synthetic polymer
Seizure suppression in kindled rats by intraventricular grafting of an adenosine releasing synthetic polymer
复制标题
DOI:
10.1006/exnr.1999.7209
复制
发表时间:
1999-11-01
影响因子:
5.3
通讯作者:
Mohler, H
中科院分区:
文献类型:
--
作者:
Boison, D;Scheurer, L;Mohler, H
Adenosine, an endogenous inhibitory neuromodulator in the central nervous system, exerts anticonvulsant activity that is largely based on the inhibition of the release of excitatory amino acids. As a novel approach to treat pharmacoresistant partial epilepsies, the grafting of adenosine-releasing cells is foreseen to provide a local and sustained source of adenosine, The feasibility of this cell-based therapy was investigated in the present study by the intraventricular implantation of synthetic polymers that release adenosine. Kindled rats with a ventricular implant of an adenosine-releasing polymer showed a profound reduction of seizure activity. This was demonstrated not only by a 75% reduction of grade 5 seizures but also by a reduction of the amplitude and duration of afterdischarges in electroencephalographic (EEG) recordings. Kindled control rats that were implanted with bovine serum albumin (BSA)-containing polymers or were sham operated, continued to show their presurgery seizure pattern. Adenosine displayed antiepileptic activity when released in an amount of 20-50 ng per day. This finding sets the target for the required amount of adenosine to be released from future adenosine-releasing cells for antiepileptic therapy. The present results clearly support the feasibility of a novel therapy for epilepsy based on adenosine-releasing cells. (C) 1999 Academic Press.